Vanguard Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.63M Buy
264,658
+16,451
+7% +$224K ﹤0.01% 1234
2026
Q2
$3.36M Buy
248,207
+19,435
+8% +$232K ﹤0.01% 1284
2026
Q1
$1.37M Buy
+228,772
New +$1.72M ﹤0.01% 1643

Other funds holding OGN

Vanguard Asset Management's OGN Position: Q3 2026 in Review

Vanguard Asset Management increased its Organon & Co (OGN) stake by 6.6% in Q3 2026, buying an estimated $224K and bringing the position to 264,658 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

Vanguard Asset Management first reported a position in OGN in Q1 2026 and has held it in 3 quarters since. 608 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Vanguard Asset Management held 264,658 shares of Organon & Co worth $3.63M as of Q3 2026.
  • Vanguard Asset Management bought 16,451 Organon & Co shares in Q3 2026, an estimated $224K.
  • Organon & Co made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1234 holding.
  • Vanguard Asset Management first reported a position in Organon & Co in Q1 2026 and has held it in 3 quarters since.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.